In situations in which you may well call for entry to a medically-vital drug for a significant or lifestyle-threatening issue exactly where there is no current market authorized drug out there in copyright and for which different typical therapies have failed or are unsuitable, Health copyright's Specific Access Programme (SAP) is on the market to